HK
BIIB icon

Horizon Kinetics’s Biogen BIIB Stock Holding History

Horizon Kinetics’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1.34M Sell
4,450
-75
-2% -$23.9K 0.04% 133
2018
Q3 		$1.6M Sell
4,525
-50
-1% -$17.2K 0.04% 138
2018
Q2 		$1.33M Hold
4,575
– – 0.03% 149
2018
Q1 		$1.25M Sell
4,575
-70
-2% -$21.7K 0.04% 154
2017
Q4 		$1.48M Hold
4,645
– – 0.04% 146
2017
Q3 		$1.45M Hold
4,645
– – 0.04% 147
2017
Q2 		$1.26M Hold
4,645
– – 0.04% 166
2017
Q1 		$1.27M Sell
4,645
-2,010
-30% -$568K 0.04% 164
2016
Q4 		$1.89M Sell
6,655
-1,050
-14% -$311K 0.06% 125
2016
Q3 		$2.41M Hold
7,705
– – 0.07% 113
2016
Q2 		$1.86M Hold
7,705
– – 0.05% 133
2016
Q1 		$2.01M Hold
7,705
– – 0.05% 125
2015
Q4 		$2.36M Sell
7,705
-8
-0.1% -$2.3K 0.05% 115
2015
Q3 		$2.25M Sell
7,713
-620
-7% -$205K 0.04% 124
2015
Q2 		$3.37M Sell
8,333
-115
-1% -$46.2K 0.05% 122
2015
Q1 		$3.57M Sell
8,448
-69
-0.8% -$27.2K 0.05% 119
2014
Q4 		$2.89M Buy
8,517
+49
+0.6% +$15.9K 0.04% 145
2014
Q3 		$2.8M Sell
8,468
-25
-0.3% -$8.24K 0.04% 135
2014
Q2 		$2.68M Hold
8,493
– – 0.03% 143
2014
Q1 		$2.6M Sell
8,493
-39
-0.5% -$12.4K 0.03% 148
2013
Q4 		$2.38M Sell
8,532
-51
-0.6% -$13.2K 0.03% 152
2013
Q3 		$2.07M Sell
8,583
-43
-0.5% -$9.62K 0.03% 154
2013
Q2 		$1.86M Buy
+8,626
New +$1.84M 0.03% 170

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Horizon Kinetics's BIIB Position: Q4 2018 in Review

Horizon Kinetics reduced its Biogen (BIIB) stake by 1.7% in Q4 2018, selling an estimated $23.9K and leaving 4,450 shares worth $1.34M. The position accounts for 0.04% of the portfolio, ranked #133.

Horizon Kinetics first reported a position in BIIB in Q2 2013 and has held it in 23 quarters since. The position peaked at $3.57M in Q1 2015. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Horizon Kinetics held 4,450 shares of Biogen worth $1.34M as of Q4 2018.
  • Horizon Kinetics sold 75 Biogen shares in Q4 2018, an estimated $23.9K.
  • Biogen made up 0.04% of Horizon Kinetics's portfolio in Q4 2018, its #133 holding.
  • Horizon Kinetics first reported a position in Biogen in Q2 2013 and has held it in 23 quarters since.
  • Horizon Kinetics's Biogen position peaked at $3.57M in Q1 2015.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.